Wells Fargo’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Wells Fargo’s Portfolio XAGE Stock Details XAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,000	Closed	-$2.52K	–	7485
2025 Q2	$2.52K	Buy	+1,000	New	+$3.65K	﹤0.01%	6189
2024 Q2	–	Sell	-4	Closed	-$310	–	7585
2024 Q1	$310	Hold	4	–	–	﹤0.01%	6394
2023 Q4	$453	Buy	4 +1	+33%	+$85	﹤0.01%	6409
2023 Q3	$310	Buy	+3	New	+$452	﹤0.01%	6469

Other funds holding XAGE

DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return

CMU

Carnegie Mellon University Pittsburgh, Pennsylvania $78.9M AUM 38.67% 1-Year Est. Return

BSB

Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return

Wells Fargo's XAGE Position: Q3 2025 in Review

Wells Fargo sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2025, closing a stake of 1,000 shares — an estimated $2.52K sold.

Wells Fargo first reported a position in XAGE in Q3 2023 and held it in 4 quarters. The position peaked at $2.52K in Q2 2025. 3 funds tracked by Wall St. Rank hold XAGE as of Q3 2025.

Wells Fargo reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
Wells Fargo sold 1,000 Longevity Health Holdings, Inc. Common Stock shares in Q3 2025, an estimated $2.52K.
Wells Fargo first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2023 and held it in 4 quarters.
Wells Fargo's Longevity Health Holdings, Inc. Common Stock position peaked at $2.52K in Q2 2025.
3 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.